Sumit K. Subudhi
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Viral Infections and Immunology Research, Immunotherapy and Immune Responses, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade(2013)990 cited
- → Immune checkpoint therapy—current perspectives and future directions(2023)945 cited
- → The Next Decade of Immune Checkpoint Therapy(2021)721 cited
- → Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis(2018)703 cited
- → Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy(2014)696 cited
- → Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells(2003)656 cited
- → VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer(2017)587 cited
- → Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial(2020)385 cited
- → Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy(2019)376 cited
- → Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers(2018)371 cited